References,Sample size,Interventions,Main race,Female (%),Mean HAMA,Mean age (Year),Attrition rate (%),Sponsor,Follow-up time (weeks),Diagnosis criteria
"Stein et al., 2014",412,agomelatine: 25-50 mg/day,NA,71.6,28.6,42.6,16.5,Servier,12,dsm-iv-tr
"Stein et al., 2014",412,escitalopram: 10-20 mg/day,NA,71.6,28.6,42.6,18.3,Servier,12,dsm-iv-tr
"Stein et al., 2014",412,placebo,NA,71.6,28.2,42.6,26.7,Servier,12,dsm-iv-tr
